OBMCX
Price
$51.04
Change
+$0.12 (+0.24%)
Updated
Sep 8 closing price
Net Assets
836.59M
VEXRX
Price
$112.69
Change
+$0.25 (+0.22%)
Updated
Sep 8 closing price
Net Assets
20.46B
Interact to see
Advertisement

OBMCX vs VEXRX

Header iconOBMCX vs VEXRX Comparison
Open Charts OBMCX vs VEXRXBanner chart's image
Oberweis Micro-Cap
Price$51.04
Change+$0.12 (+0.24%)
VolumeN/A
Net Assets836.59M
Vanguard Explorer Adm
Price$112.69
Change+$0.25 (+0.22%)
VolumeN/A
Net Assets20.46B
OBMCX vs VEXRX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
OBMCX vs. VEXRX commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OBMCX is a Buy and VEXRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEXRX has more cash in the bank: 20.5B vs. OBMCX (837M). VEXRX pays higher dividends than OBMCX: VEXRX (0.50) vs OBMCX (0.00). OBMCX was incepted earlier than VEXRX: OBMCX (30 years) vs VEXRX (24 years). OBMCX (1.47) is less costly to investors than VEXRX (0.33). OBMCX is a more actively managed with annual turnover of: 51.00 vs. VEXRX (35.00). OBMCX has a lower initial minimum investment than VEXRX: OBMCX (1000) vs VEXRX (50000). OBMCX annual gain was more profitable for investors over the last year : 22.11 vs. VEXRX (2.61). OBMCX return over 5 years is better than : 147.30 vs. VEXRX (12.06).
OBMCXVEXRXOBMCX / VEXRX
Total Expense Ratio1.470.33445%
Annual Report Gross Expense Ratio1.470.33445%
Fund Existence30 years24 years-
Gain YTD12.9555.232248%
Front LoadN/AN/A-
Min. Initial Investment1000500002%
Min. Initial Investment IRAN/AN/A-
Net Assets837M20.5B4%
Annual Yield % from dividends0.000.50-
Returns for 1 year22.112.61847%
Returns for 3 years67.6722.01307%
Returns for 5 years147.3012.061,222%
Returns for 10 years176.8931.16568%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RKLB45.842.85
+6.63%
Rocket Lab Corporation
AGEN4.330.04
+0.93%
Agenus
SABR1.71-0.01
-0.58%
Sabre Corp
COLM56.50-1.02
-1.77%
Columbia Sportswear Company
ADAP0.04-0.01
-19.61%
Adaptimmune Therapeutics plc